Beacon Trust’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Beacon Trust's AMGN Position: Q1 2017 in Review
Beacon Trust reduced its Amgen (AMGN) stake by 1% in Q1 2017, selling an estimated $98.5K and leaving 58,709 shares worth $10.4M. The position accounts for 1.63% of the portfolio, ranked #14.
Beacon Trust first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $11.7M in Q3 2016. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.
- Beacon Trust held 58,709 shares of Amgen worth $10.4M as of Q1 2017.
- Beacon Trust sold 593 Amgen shares in Q1 2017, an estimated $98.5K.
- Amgen made up 1.63% of Beacon Trust's portfolio in Q1 2017, its #14 holding.
- Beacon Trust first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
- Beacon Trust's Amgen position peaked at $11.7M in Q3 2016.
- 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.
Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.